Hence, working with them can offer the advantages of larger cohorts, leading to more statistical power, and also the inclusion of rare entities for which frozen tissues are not always available, such as morphologically low-grade diffuse IDH-wt gliomas. The gene discussed is IDH1; the disease is central nervous system cancer.